H. A. A. El-Nabi / Tetrahedron 58 (2002) 135±141
139
N, 14.94%); Rf (benzene/chloroform, 10:3) 0.36; nmax (KBr)
2200, 1675 and 1620 cm21; dH (200 MHz, CDCl3, TMS)
7.23±7.84 (m, 4H, Ar), 4.79 (s, 1H, C4-H), 3.80 (s, 3H,
OCH3), 3.62 (s, 3H, p-OCH3). dC (100 MHz, CDCl3,
TMS) 166.07, 164.78, 158.92, 145.84, 134.26, 132.25,
116.47, 116.11, 95.20, 84.94, 57.30, 56.65.
temperature, ethanol was removed in vacuo, and the concen-
trated reaction mixture was then poured into a separatory
funnel containing ice cold water (100 mL) and methylene
chloride (100 mL). The organic layer was separated and
dried over anhydrous MgSO4. Filtration and concentration
in vacuogave 8a±c in 85±93% yields.
4.1.9. 7-Aryl-8-methoxy-1-(methylsulfanyl)-2,7-diaza-
spiro[4.4]nona-1,8-dien-6-one (6a±c). A mixture of 2a±c
(1 mmol) and aziridine (5 mmol) in dry diethyl ether
(100 mL) was stirred at 0±58C for 2±4 h. Removal of the
solvent under reduced pressure yielded 5a±c. The isomeri-
zation of 5a±c to 6a±c was achieved by heating in xylene
for 2 h yielded the spiro compounds 6a±c in 60±65% yield
which then recrystallized from ethanol.
4.1.14. 3-[Di(methylsulfanyl)methylene]-5-methoxy-1-
phenyl-2,3-dihydro-1H-2-pyrrolone oxime (8a). 0.261 g,
85%; as colorless needles mp 186±1878C (Found: C, 54.28;
H, 5.02; N, 8.89; S, 20.61. C14H16N2O2S2 requires C, 54.52;
H, 5.23; N, 9.08; S, 20.79%); Rf (petroleum ether/ether, 1:1)
0.22; nmax (KBr) 3500±3300 cm21; dH (200 MHz, CDCl3,
TMS) 9.98 (s, 1H, OH), 7.18±7.57 (m, 5H, Ph), 5.76 (s, 1H,
C4-H), 3.52 (s, 3H, OCH3), 2.55 (s, 6H, 2SCH3). dC
(100 MHz, CDCl3, TMS) 156.52, 153.75, 147.91, 140.14,
137.85, 131.12, 123.84, 122.10, 87.96, 52.87, 17.64.
4.1.10. 3-Methoxy-6-(methylsulfanyl)-2-phenyl-2,7-di-
azaspiro[4.4]nona-3,6-dien-1-one (6a). 0.187 g, 65%; as
pale yellow powder mp 166±1678C (Found: C, 62.34; H,
5.52; N, 9.63; S, 10.89. C15H16N2O2S requires C, 62.48; H,
5.59; N, 9.71; S, 11.12%); Rf (benzene/acetone, 10:2) 0.32;
nmax (KBr) 1685 and 1630 cm21; dH (200 MHz, CDCl3,
TMS) 7.31±7.72 (m, 5H, Ph), 3.80±3.86 (m, 2H, NCH2),
3.77 (s, 3H, OCH3), 4.29 (s, 1H, C4-H), 2.35±2.50 (m, 2H,
CH2), 2.45 (s, 3H, SCH3). dC (100 MHz, CDCl3, TMS)
171.85, 161.47, 147.43, 134.68, 131.89, 127.58, 120.52,
90.46, 59.87, 53.69, 44.87, 34.95, 13.62.
4.1.15. 3-[Di(methylsulfanyl)methylene]-5-methoxy-1-
(4-methylphenyl)-2,3-dihydro-1H-2-pyrroloneoxime (8b).
0.289 g, 90%; as colorless needles mp 186±1878C (Found:
C, 55.63; H, 5.42; N, 8.52; S, 19.67. C15H18N2O2S2 requires
C, 55.88; H, 5.63; N, 8.69; S, 19.89%); Rf (petroleum ether/
ether, 1:1) 0.24; nmax (KBr) 3500±3300 cm21; dH (200
MHz, CDCl3, TMS) 10.05 (s, 1H, OH), 7.22±7.78 (m,
4H, Ar), 5.64 (s, 1H, C4-H), 3.48 (s, 3H, OCH3), 2.50 (s,
6H, 2SCH3), 2.28 (s, 3H, CH3). dC (100 MHz, CDCl3, TMS)
157.60, 154.21, 148.12, 140.35, 138.90, 135.65, 130.58,
123.66, 88.15, 53.13, 21.01, 17.85.
4.1.11. 3-Methoxy-2-(4-methylphenyl)-6-(methylsulfanyl)-
2,7-diazaspiro[4.4]nona-3,6-dien-1-one (6b). 0.181 g,
60%; as pale yellow powder mp 142±1438C (Found: C,
63.32; H, 5.87; N, 9.11; S, 10.32. C16H18N2O2S requires
C, 63.55; H, 6.00; N, 9.26; S, 10.60%); Rf (benzene/acetone,
10:2) 0.35; nmax (KBr) 1675 and 1630 cm21. dH (200 MHz,
CDCl3, TMS) 7.23±7.58 (m, 4H, Ar), 3.84±3.90 (m, 2H,
NCH2), 3.81 (s, 3H, OCH3), 4.31 (s, 1H, C4-H), 2.37±2.48
(m, 2H, CH2), 2.43 (s, 3H, SCH3), 2.28 (s, 3H, CH3). dC
(100 MHz, CDCl3, TMS) 172.19, 162.42, 148.55, 135.72,
132.99, 131.86, 128.91, 91.88, 60.69, 55.73, 45.67, 35.59,
21.01, 13.58.
4.1.16. 3-[Di(methylsulfanyl)methylene]-5-methoxy-1-
(4-methoxyphenyl)-2,3-dihydro-1H-2-pyrrolone oxime
(8c). 0.314 g, 93%; as colorless needles mp 162±1638C
(Found: C, 53.00; H, 5.09; N, 8.00; S, 18.74.
C15H18N2O3S2 requires C, 53.23; H, 5.36; N, 8.28; S,
18.95%); Rf (petroleum ether/ether 1:1) 0.26; nmax (KBr)
3500±3300 cm21; dH (200 MHz, CDCl3, TMS) 9.95 (s,
1H, OH), 7.03±7.68 (m, 4H, Ar), 5.76 (s, 1H, C4-H), 3.69
(s, 3H, p-OCH3), 2.55 (s, 6H, SCH3), 2.52 (s, 3H, OCH3). dC
(100 MHz, CDCl3, TMS) 158.90, 158.49, 154.53, 149.21,
142.25, 133.31, 124.70, 116.03, 88.45, 57.30, 53.25, 17.85.
4.1.12. 3-Methoxy-2-(4-methoxyphenyl)-6-(methylsul-
fanyl)-2,7-diazaspiro[4.4]nona-3,6-dien-1-one (6c). 0.2 g,
63%; as pale yellow powder mp 186±1878C (Found: C,
60.12; H, 5.57; N, 8.71; S, 9.86. C16H18N2O3S requires C,
60.36; H, 5.70; N, 8.80; S, 10.07%); Rf (benzene/acetone,
10:2) 0.41; nmax (KBr) 1675 and 1635 cm21. dH (200 MHz,
CDCl3, TMS) 7.08±7.45 (m, 4H, Ar), 3.92±3.96 (m, 2H,
NCH2), 3.79 (s, 3H, OCH3), 3.69 (s, 3H, p-OCH3), 4.29 (s,
1H, C4-H), 2.40±2.47 (m, 2H, CH2), 2.47 (s, 3H, SCH3). dC
(100 MHz, CDCl3, TMS) 173.25, 163.32, 159.75, 149.54,
131.54, 128.91, 116.45, 92.43, 59.47, 56.37, 57.30, 45.88,
36.31, 14.24.
4.1.17. 6-Aryl-5-methoxy-3-(methylsulfanyl)-6H-pyrrolo-
[2,3-c]isoxazole (9a±c). Heating of oxime 8a±c (1 mmol)
in dry xylene (30 mL) tore¯ux and stirred for 2±3 h. The
progress of reaction was monitored by TLC and worked
up when starting material had completely disappeared.
Removal of the solvent in vacuo afforded crude isoxazoles
9a±c as a pale yellow powder in 90±95% yields. The crude
products were relatively clean. Analytical pure samples
were obtained by ¯ash chromatography using toluene/
acetone (10:1).
4.1.18.
5-Methoxy-3-(methylsulfanyl)-6-phenyl-6H-
4.1.13. 1-Aryl-3-[di(methylsulfanyl)methylene]-5-methoxy-
2,3-dihydro-1H-2-pyrrolone oxime (8a±c). An aqueous
ethanol hydroxylamine solution was generated from
hydroxylamine hydrocloride (3.46 g, 5 mmol), KOH
(2.8 g, 5 mmol) in water (10 mL), and 95% ethanol
(50 mL). The clear solution was neutral to litmus paper.
To this hydroxylamine solution was added 1 mmol of the
appropriate ketene dithioacetal. The solution was heated to
re¯ux and stirred for 24 h. The solution was cooled to room
pyrrolo[2,3-c]isoxazole (9a). 0.234 g, 90%; as colorless
needles mp 198±1998C (Found: C, 59.69; H, 4.42; N,
10.46; S, 12.11. C13H12N2O2S requires C, 59.98; H, 4.65;
N, 10.76; S, 12.32%); Rf (petroleum ether/ether, 1:1) 0.27;
nmax (KBr) 3050, 1640 cm21; dH (200 MHz, CDCl3, TMS)
7.05±7.52 (m, 5H, Ph), 4.78 (s, 1H, C4-H), 3.95 (s, 3H,
OCH3), 2.65 (s, 3H, SCH3). dC (100 MHz, CDCl3, TMS)
156.19, 150.63, 139.80, 136.16, 131.12, 122.10, 121.35,
117.76, 86.16, 55.46, 20.64.